Overcoming resistance to HER2 inhibitors through state-specific kinase binding.
about
Pseudokinases: update on their functions and evaluation as new drug targets.Pseudoscaffolds and anchoring proteins: the difference is in the details.Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma.Investigation of nepetolide as a novel lead compound: Antioxidant, antimicrobial, cytotoxic, anticancer, anti-inflammatory, analgesic activities and molecular docking evaluation.Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface.Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes.Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer
P2860
Q30397636-3A573E47-534B-4931-802F-7FCB8A4F2544Q33872666-D396FE8D-6FA8-4F5E-BCED-DB2F9190F268Q47114555-BA6C9F24-C00F-4B74-AF16-2F529BD574AEQ52647819-1A6CDB42-261F-4A7D-A6E0-2E469547CA6CQ52715470-DFBFA047-50F6-45F0-89D6-850755BC79C8Q53078543-4B10A5D4-B86E-48AA-B806-30736D5FA24BQ58803127-B43B3C0A-975D-4CC5-9158-01758C5431AB
P2860
Overcoming resistance to HER2 inhibitors through state-specific kinase binding.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Overcoming resistance to HER2 inhibitors through state-specific kinase binding.
@en
type
label
Overcoming resistance to HER2 inhibitors through state-specific kinase binding.
@en
prefLabel
Overcoming resistance to HER2 inhibitors through state-specific kinase binding.
@en
P2093
P2860
P356
P1476
Overcoming resistance to HER2 inhibitors through state-specific kinase binding.
@en
P2093
Chris J Novotny
Jin H Park
Kevan M Shokat
Sirkku Pollari
P2860
P2888
P304
P356
10.1038/NCHEMBIO.2171
P577
2016-09-05T00:00:00Z
P6179
1021624784